Vaccines against melanoma
US5141742A · kind A · utility
28Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 13, 1991 |
| Grant date | Aug 25, 1992 |
| Priority date | — |
| Expiry date | May 13, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/876
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Peptides or proteins related to a melanoma associated antigen are described. These are produced in large quantities via recombinant DNA techniques and/or by chemical synthetic methods. The peptides or proteins can be used as immunogens in vaccine formulations which can induce an immune response that selectively destroys melanoma cells in a vaccinated individual. Where the peptides or proteins are expressed by a recombinant virus, inactivated or live virus vaccine formulations may be prepared.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.